The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma

被引:49
|
作者
Wong, Andrew T. [1 ,2 ]
Shao, Meng [1 ,2 ]
Rineer, Justin [3 ]
Lee, Anna [1 ,2 ]
Schwartz, David [1 ,2 ]
Schreiber, David [1 ,2 ]
机构
[1] Dept Vet Affairs New York Harbor Healthcare Syst, Dept Radiat Oncol, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Radiat Oncol, 450 Clarkson Ave,Box 1211, Brooklyn, NY 11203 USA
[3] UF Hlth Canc Ctr Orlando Hlth, Dept Radiat Oncol, Orlando, FL USA
关键词
chemotherapy; esophageal cancer; esophagectomy; radiation therapy; SQUAMOUS-CELL CARCINOMA; THORACIC ESOPHAGUS; RANDOMIZED TRIAL; RADIOTHERAPY; SURGERY; CANCER; CHEMORADIOTHERAPY; RESECTION;
D O I
10.1097/SLA.0000000000001825
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to analyze the impact on overall survival (OS) from the addition of postoperative radiation with or without chemotherapy after esophagectomy, using a large, hospital-based dataset. Background: Previous retrospective studies have suggested an OS advantage for postoperative chemoradiation over surgery alone, although prospective data are lacking. Methods: The National Cancer Data Base was queried to select patients diagnosed with stage pT3-4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treated with definitive esophagectomy +/- postoperative radiation and/or chemotherapy. OS was analyzed using the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to identify covariates associated with OS. Results: There were 4893 patients selected, of whom 1153 (23.6%) received postoperative radiation. Most patients receiving radiation also received sequential/concomitant chemotherapy (89.9%). For the entire cohort, postoperative radiation was associated with a statistically significant but modest absolute improvement in survival (hazard ratio 0.77; 95% CI, 0.71-0.83; P < 0.001). On subgroup analysis, postoperative radiation was associated with improved OS for patients with node-positive disease (3-yr OS 34.3 % vs 27.8%, P < 0.001) or positive margins (3-yr OS 36.4% vs 18.0%, P < 0.001). When chemotherapy usage was incorporated, sequential chemotherapy was associated with the best survival (P < 0.001). Multivariate analysis revealed that the addition of chemotherapy to radiation therapy, whether sequentially or concurrently, was a strong prognostic factor for OS. Conclusions: In this hospital-based study, the addition of postoperative chemoradiation (either sequentially or concomitantly) after esophagectomy was associated with improved OS for patients with node-positive disease or positive margins.
引用
下载
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [41] Adjuvant (Postoperative) Therapy for Esophageal Cancer
    Ku, Geoffrey Y.
    Ilson, David H.
    THORACIC SURGERY CLINICS, 2013, 23 (04) : 525 - +
  • [42] Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy
    Okuda, Sho
    Ohuchida, Kenoki
    Shindo, Koji
    Moriyama, Taiki
    Kawata, Jun
    Tamura, Koji
    Sada, Masafumi
    Nagayoshi, Kinuko
    Mizuuchi, Yusuke
    Ikenaga, Naoki
    Nakata, Kohei
    Oda, Yoshinao
    Nakamura, Masafumi
    ONCOLOGY LETTERS, 2022, 24 (04)
  • [43] The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer
    Li, Kun-Kun
    Wang, Yin-Jian
    Liu, Xue-Hai
    Tan, Qun-You
    Jiang, Yao-Guang
    Guo, Wei
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (09): : 3475 - 3482
  • [44] The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer
    Kun-Kun Li
    Yin-Jian Wang
    Xue-Hai Liu
    Qun-You Tan
    Yao-Guang Jiang
    Wei Guo
    Surgical Endoscopy, 2017, 31 : 3475 - 3482
  • [45] Postoperative inflammatory markers predict survival in patients after McKeown esophagectomy for esophageal cancer
    Takahashi, Keita
    Masuda, Takahiro
    Ishikawa, Yoshitaka
    Tanishima, Yuichiro
    Kurogochi, Takanori
    Yuda, Masami
    Tanaka, Yujiro
    Matsumoto, Akira
    Yano, Fumiaki
    Eto, Ken
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (02) : 196 - 206
  • [46] Poor Survival Rate in Patients with postoperative Pneumonia after Radical Esophagectomy for Esophageal Cancer
    Booka, E.
    Takeuchi, H.
    Nishi, T.
    Matsuda, S.
    Fukuda, K.
    Nakamura, R.
    Takahashi, T.
    Wada, N.
    Kawakubo, H.
    Saikawa, Y.
    Omori, T.
    Kitagawa, Y.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S150 - S150
  • [47] Association of adjuvant chemotherapy with improved survival after esophagectomy without induction therapy for node-positive adenocarinoma.
    Speicher, Paul J.
    Englum, Brian R.
    Ganapathi, Asvin M.
    Onaitis, Mark W.
    D'Amico, Thomas A.
    Berry, Mark F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Use of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma Limited to the Pelvis
    Wong, Andrew T.
    Lee, Yi-Chun
    Schwartz, David
    Lee, Anna
    Shao, Meng
    Han, Peter
    Choi, Kwang
    Schreiber, David
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (06) : 1160 - 1166
  • [49] Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
    Zhao, Zhiyong
    Huang, Xiaolong
    Gu, Ting
    Chen, Zhu
    Gan, Limin
    Zhu, Biao
    Wu, Ning
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [50] Preoperative or postoperative radiation improves survival in locally advanced esophageal carcinoma
    Schreiber, D.
    Rineer, J.
    Vongtama, D.
    Kim, A.
    Wortham, A.
    Han, P.
    Nwokedi, E.
    Choi, K.
    Rotman, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S254 - S255